A topical insect repellent and insecticide composition for cats and dogs that includes a lotion including active and inert ingredients. The active ingredients include cedarwood oil, rosemary oil, and thyme oil and the inert ingredients include sunflower oil, isopropyl myristate, decanoic acid, lauric acid, water, vanillin, lecithin, and triethyl citrate.

A topical skin composition containing a sphingolipid having a branched chain fatty acid as an active ingredient and its uses are disclosed. The topical composition is useful in preventing adsorption of fine dust, improving a skin barrier function, and exhibiting an excellent skin moisture effect. A preparation method for the topical composition is also disclosed.

The present invention relates to a transdermal delivery complex using a metal-organic framework (MOF) and nanocellulose. In addition, the present invention relates to a cosmetic composition comprising the transdermal delivery complex and a method for preparation of a transdermal delivery complex.

The invention provides a topical o/w emulsion which moisturizes, and protects, repairs or restores the skin lipid barrier of a mammal. The topical o/w emulsion composition comprises: (a) a discontinuous oil phase; (b) a continuous aqueous phase comprising water; (c) a thickening agent; (d) at least one lamellar membrane structure comprising (i) a phospholipid, (ii) a fatty alcohol, and (iii) a fatty acid; and wherein in use the composition has a water vapor transmission rate of less than about 70 g.m.sup.−2.hr.sup.−1 measured in vitro using the modWVTR test methodology.

A composition for restorative vaginal lubrication and a method of use thereof facilitates enhances the overall vaginal health. The composition includes a quantity of water, a quantity of glycerin, a quantity of cetearyl alcohol, a quantity of glyceryl stearate, a quantity of avocado oil, a quantity of squalene oil, a quantity of lecithin, a quantity of benzoin oil, a quantity of xanthan gum, a quantity of citric acid, a quantity of potassium sorbate, a quantity of Dehydroepiandrosterone (DHEA), a quantity of elderberry extract, a quantity of damiana extract, a quantity of progesterone, a quantity of pomegranate oil, and a quantity of sodium benzoate. The composition is homogeneously mixed into a vaginal salve that may be both externally and internally applied with the vaginal area in order to moisturize the vaginal area and enhance sexual pleasure during sexual activity. The vaginal salve also promotes blood circulation for the vaginal area.

The present invention relates to a cosmetic composition for treating keratin fibres, preferably human keratin fibres such as the hair, comprising, in a cosmetically acceptable medium: —one or more chemical oxidizing agents, —one or more scleroglucan gums, —one or more phosphorus-based sequestrants. The present invention also relates to a process for treating keratin fibres, preferably human keratin fibres such as the hair, comprising the application of the composition to the keratin fibres. The process according to the invention is preferably a process for bleaching, dyeing or permanently reshaping keratin fibres.

Personal care devices (or apparatuses) are described to deliver/activate a bioactive compound/botanical compound/biologically active molecule (including a regulatory protein/growth factor) or a mixture of bioactive compounds/botanical compounds/biologically active molecules (including regulatory proteins/growth factors) for growth and protection of hair or rejuvenation and protection of skin, which utilizes nanoencapsulation/nanoemulsion and/or activation/photoactivation. Such devices (or apparatuses) utilize a light low intensity module/x-ray and nanooptical elements/three-dimensionally (3-D) printed micro/nanostructures. Furthermore, the personal care devices (or apparatuses) can be enhanced with an artificial intelligence (AI) algorithm and/or augmented reality (AR) application (app).

A skin care composition comprising: (i) a medium having a mixture of two or more immiscible phases; (ii) 0.1 wt. % to 10 wt. % of a terpolymer of vinyl pyrrolidone/acrylic acid/lauryl methacrylate having a relative viscosity of at least 3.3 cps; and (iii) 0.1 wt. % to 20 wt. % of at least one cosmetically/dermatologically acceptable skin care additive; wherein the skin care composition is free from surfactant(s), also discloses about skin care composition comprising surfactants. Other important embodiments of this application disclose about specific sun care compositions with surfactants/without surfactants system. In another embodiment, it also discloses about a method for providing an enhanced care to skin of humans or animals employing various compositions that are disclosed in this application.

Methods are provided for producing a gelatinous composition containing a phospholipid, which has excellent emulsion stability, as well as methods for easily producing an emulsified composition that is excellent in use feeling and emulsion stability. Gelatinous compositions having excellent emulsion stability, and emulsified compositions having excellent use feeling and emulsion stability are also provided. The methods for producing the gelatinous compositions and emulsified compositions comprise dissolving a phospholipid and a cyclic lipopeptide biosurfactant in a polyol solvent or a mixed solvent of water and a polyol to obtain a surfactant solution, and mixing an oily ingredient with the surfactant solution to obtain a gelatinous composition, wherein a mass ratio of the cyclic lipopeptide biosurfactant to the phospholipid in the gelatinous composition is 0.25 or more.

The present invention relates to a hybrid-type multi-lamellar nanostructure of an epidermal growth factor and a liposome and a method for manufacturing same. The new type of hybrid-type multi-lamellar nanostructure not only has a high epidermal growth factor encapsulating efficiency, but also can be manufactured through a simple process, such that the same can be easily delivered into a living body or a cell while maintaining a high physiological activity of the epidermal growth factor.